
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Down-regulation of CXCL 11 inhibits colorectal cancer cell growth and epithelial-mesenchymal transition
Yu Gao, De Lin Liu, Sheng Li, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 7333-7343
Open Access | Times Cited: 44
Yu Gao, De Lin Liu, Sheng Li, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 7333-7343
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
CXCL11 Correlates With Antitumor Immunity and an Improved Prognosis in Colon Cancer
Yingying Cao, Nanlin Jiao, Tiantian Sun, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 118
Yingying Cao, Nanlin Jiao, Tiantian Sun, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 118
Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells
Hyun Jung Hwang, Ye-Rim Lee, Donghee Kang, et al.
Cancer Letters (2020) Vol. 490, pp. 100-110
Closed Access | Times Cited: 114
Hyun Jung Hwang, Ye-Rim Lee, Donghee Kang, et al.
Cancer Letters (2020) Vol. 490, pp. 100-110
Closed Access | Times Cited: 114
Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11
Xing Zeng, Ke Chen, Le Li, et al.
Free Radical Biology and Medicine (2022) Vol. 184, pp. 135-147
Closed Access | Times Cited: 44
Xing Zeng, Ke Chen, Le Li, et al.
Free Radical Biology and Medicine (2022) Vol. 184, pp. 135-147
Closed Access | Times Cited: 44
The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment
Nathan Reynders, Dayana Abboud, Alessandra Baragli, et al.
Cells (2019) Vol. 8, Iss. 6, pp. 613-613
Open Access | Times Cited: 73
Nathan Reynders, Dayana Abboud, Alessandra Baragli, et al.
Cells (2019) Vol. 8, Iss. 6, pp. 613-613
Open Access | Times Cited: 73
Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights
Xinchen Tian, Tinghao Yan, Fen Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Xinchen Tian, Tinghao Yan, Fen Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Expression Pattern and Prognostic Significance of Chemokines in Breast cancer: An Integrated Bioinformatics Analysis
Umar Mehraj, Bader Alshehri, Azmat Ali Khan, et al.
Clinical Breast Cancer (2022) Vol. 22, Iss. 6, pp. 567-578
Closed Access | Times Cited: 34
Umar Mehraj, Bader Alshehri, Azmat Ali Khan, et al.
Clinical Breast Cancer (2022) Vol. 22, Iss. 6, pp. 567-578
Closed Access | Times Cited: 34
Identification of differentially expressed genes and biological characteristics of colorectal cancer by integrated bioinformatics analysis
Guangwei Sun, Yalun Li, Yangjie Peng, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 9, pp. 15215-15224
Closed Access | Times Cited: 54
Guangwei Sun, Yalun Li, Yangjie Peng, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 9, pp. 15215-15224
Closed Access | Times Cited: 54
CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7
Malte Puchert, Jessica Obst, Christian Koch, et al.
Cytokine (2019) Vol. 125, pp. 154809-154809
Closed Access | Times Cited: 42
Malte Puchert, Jessica Obst, Christian Koch, et al.
Cytokine (2019) Vol. 125, pp. 154809-154809
Closed Access | Times Cited: 42
Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics
Benjiao Gong, Yanlei Kao, Chenglin Zhang, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 39
Benjiao Gong, Yanlei Kao, Chenglin Zhang, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 39
CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers
Subhashree Kumaravel, Sumeet Pal Singh, Sukanya Roy, et al.
American Journal Of Pathology (2020) Vol. 190, Iss. 4, pp. 900-915
Open Access | Times Cited: 36
Subhashree Kumaravel, Sumeet Pal Singh, Sukanya Roy, et al.
American Journal Of Pathology (2020) Vol. 190, Iss. 4, pp. 900-915
Open Access | Times Cited: 36
CXCL1 Regulated by miR-302e Is Involved in Cell Viability and Motility of Colorectal Cancer via Inhibiting JAK-STAT Signaling Pathway
Biyin Chen, Li Song, Xiuzhen Nie, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 32
Biyin Chen, Li Song, Xiuzhen Nie, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 32
Colorectal cancer extracellular acidosis decreases immune cell killing and is partially ameliorated by pH-modulating agents that modify tumor cell cytokine profiles.
Kelsey E. Huntington, Anna D. Louie, Lanlan Zhou, et al.
PubMed (2022) Vol. 12, Iss. 1, pp. 138-151
Closed Access | Times Cited: 20
Kelsey E. Huntington, Anna D. Louie, Lanlan Zhou, et al.
PubMed (2022) Vol. 12, Iss. 1, pp. 138-151
Closed Access | Times Cited: 20
Construction of a CXC Chemokine-Based Prediction Model for the Prognosis of Colon Cancer
Kaisheng Liu, Minshan Lai, Shaoxiang Wang, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-12
Open Access | Times Cited: 28
Kaisheng Liu, Minshan Lai, Shaoxiang Wang, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-12
Open Access | Times Cited: 28
RAMP2-AS1 inhibits CXCL11 expression to suppress malignant phenotype of breast cancer by recruiting DNMT1 and DNMT3B
Li Li, Yaping Gan, Hui Peng
Experimental Cell Research (2022) Vol. 416, Iss. 2, pp. 113139-113139
Closed Access | Times Cited: 18
Li Li, Yaping Gan, Hui Peng
Experimental Cell Research (2022) Vol. 416, Iss. 2, pp. 113139-113139
Closed Access | Times Cited: 18
The Potential Role of PD-1/PD-L1 Small Molecule Inhibitors in Colorectal Cancer with Different Mechanisms of Action
Suhaibee Kuno, Nattaporn Pakpian, Chatchai Muanprasat
European Journal of Pharmacology (2025), pp. 177351-177351
Closed Access
Suhaibee Kuno, Nattaporn Pakpian, Chatchai Muanprasat
European Journal of Pharmacology (2025), pp. 177351-177351
Closed Access
CXCL11: A Novel Biomarker in Colorectal Cancer as Metastasis Predictor
R Marjono Dwi Wibowo, Yunia Sribudiani, Kiki Lukman, et al.
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 657-665
Open Access
R Marjono Dwi Wibowo, Yunia Sribudiani, Kiki Lukman, et al.
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 657-665
Open Access
The Role of Chemokines in the Development of Gastric Cancer—Diagnostic and Therapeutic Implications
Elżbieta Pawluczuk, Marta Łukaszewicz‐Zając, Barbara Mroczko
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8456-8456
Open Access | Times Cited: 24
Elżbieta Pawluczuk, Marta Łukaszewicz‐Zając, Barbara Mroczko
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8456-8456
Open Access | Times Cited: 24
Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer
Qian Zou, Xue Lei, Aijing Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Qian Zou, Xue Lei, Aijing Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Development and verification of an immune‐related gene pairs prognostic signature in ovarian cancer
Bao Zhang, Xiaocui Nie, Xinxin Miao, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 6, pp. 2918-2930
Open Access | Times Cited: 19
Bao Zhang, Xiaocui Nie, Xinxin Miao, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 6, pp. 2918-2930
Open Access | Times Cited: 19
Identification of key genes in cutaneous squamous cell carcinoma: a transcriptome sequencing and bioinformatics profiling study
Dandan Zou, Dan Xu, Yuanyuan Deng, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 19, pp. 1497-1497
Open Access | Times Cited: 17
Dandan Zou, Dan Xu, Yuanyuan Deng, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 19, pp. 1497-1497
Open Access | Times Cited: 17
Comprehensive Analysis of Core Genes and Potential Mechanisms in Rectal Cancer
Bao-Xin-Zi Liu, Guan‐Jiang Huang, Haibo Cheng
Journal of Computational Biology (2019) Vol. 26, Iss. 11, pp. 1262-1277
Closed Access | Times Cited: 18
Bao-Xin-Zi Liu, Guan‐Jiang Huang, Haibo Cheng
Journal of Computational Biology (2019) Vol. 26, Iss. 11, pp. 1262-1277
Closed Access | Times Cited: 18
miR-1298-5p Influences the Malignancy Phenotypes of Breast Cancer Cells by Inhibiting CXCL11
Jie Zhang, HU Da-wei
Cancer Management and Research (2021) Vol. Volume 13, pp. 133-145
Open Access | Times Cited: 13
Jie Zhang, HU Da-wei
Cancer Management and Research (2021) Vol. Volume 13, pp. 133-145
Open Access | Times Cited: 13
Identification of 10 Hub genes related to the progression of colorectal cancer by co-expression analysis
Jie Meng, Rui Su, Yun Liao, et al.
PeerJ (2020) Vol. 8, pp. e9633-e9633
Open Access | Times Cited: 13
Jie Meng, Rui Su, Yun Liao, et al.
PeerJ (2020) Vol. 8, pp. e9633-e9633
Open Access | Times Cited: 13
Siglec-15 as a New Perspective Therapy Target in Human Giant Cell Tumor of Bone
Mengke Fan, Guochuan Zhang, Mingfang Xie, et al.
Current Oncology (2022) Vol. 29, Iss. 10, pp. 7655-7671
Open Access | Times Cited: 8
Mengke Fan, Guochuan Zhang, Mingfang Xie, et al.
Current Oncology (2022) Vol. 29, Iss. 10, pp. 7655-7671
Open Access | Times Cited: 8
A combination of inhibitors of glycolysis, glutaminolysis and de�novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells
Alejandro Schcolnik‐Cabrera, Guadalupe Domínguez-Gómez, Alma Ch�vez‐Blanco, et al.
Oncology Letters (2019)
Open Access | Times Cited: 11
Alejandro Schcolnik‐Cabrera, Guadalupe Domínguez-Gómez, Alma Ch�vez‐Blanco, et al.
Oncology Letters (2019)
Open Access | Times Cited: 11